Exploristics: Press Releases
Exploristics Receives R&D Grant to Develop Personalised Medicine Simulation Tool
Exploristics, the innovative data analysis and modelling company, is pleased to announce that is has received a grant from Invest NI to develop a simulation tool to optimise the design of...
Anaxsys Receives CE Mark for its Respiratory Rate Monitor with the Support of Exploristics
Exploristics, the innovative analysis group, is pleased to announce that Anaxsys has received the CE mark for its respiratory rate monitor, respiR8, from the British Standards Institute (BSI)....
Exploristics Signs Agreement with OmicSoft Corporation
Exploristics is pleased to announce an agreement with OmicSoft Corporation. Under the terms of the agreement, Exploristics will act as the sole distributor in Europe of OmicSoft's...
Exploristics Releases New 'Management and Analysis of Biomarker Data' White Paper
Exploristics provides effective solutions to the challenge of managing, storing, integrating and analysing large volumes of biomarker data. Exploristics' recently released white paper,...
Exploristics Signs Contract with Cytos Biotechnology
Exploristics is pleased to announce a collaboration with Cytos Biotechnology, the drug discovery, development and commercialisation company specialising in therapeutic vaccines. As part of...
Exploristics Supports the Design and Validation of Clinical Rating Scales and QoL Data
Exploristics, the innovative data analysis company, is pleased to announce the release of a new service that helps clinical researchers from across the healthcare sector to design and...
Exploristics Can Discover Hidden Gems in Your Clinical Development Portfolio
Exploristics, the innovative data analysis company, is pleased to announce a new service that helps pharmaceutical and biotechnology companies identify and exploit new opportunities within...
Technical Paper on the Identification of Opportunities for Pharmacogenetics is Now Available from Exploristics
There is increasing demand in the pharmaceutical industry, in medical practice and by regulatory authorities to use new data, such as genetics, to identify patients who are likely to respond...
